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Purpose: More than 66% of the 200,000 newly diagnosed annual breast cancers in the US occurs in women over
55 years. Treatment advances result in excellent survival, yet older breast cancer survivors with co-morbidity may
live longer, but not better after cancer. Decline in physical function, increased social isolation, and diminished
economic resources increase vulnerability among older women. Rural women represent an underserved population.
The purpose is to examine associations between comorbidity and predictors of health status among older rural
breast cancer survivors.
Methods: Baseline data of 331 BCS age 55–90 years enrolled in the Rural Breast Cancer Survivors Study. Four
surveys were used for data collection. Self-reported prescription medications were used as proxy for co-morbidity.
Bivariate tests of association and multivariable recursive partitioning techniques were used for analysis.
Results: Mean number of prescription medication categories reported was 3.68 (SD = 2.3; range = 0–12). Common
prescription categories were: anti-hormonal, anti-hypertensive, and cholesterol- reducing agents. 69% was
overweight or obese. BMI >31 was significantly associated with both poorer physical and mental health. Multivariate
analyses indicated physical health status was predicted by BMI, comorbid conditions, social support, and adverse
changes in economic lifestyle. The same variables, with the exception of BMI, were predictors of mental health status.
Conclusions: Assessing co-morbid conditions, mental health status, social support, and economic burden after breast
cancer treatment may better inform cancer survivorship care and comprehensive geriatric assessment.Introduction
Breast cancer is the most common female cancer with
more than 200,000 new cases diagnosed each year in the
United States with about 66.4% occurring in women
over the age of 55 years (American Cancer Society 2013;
National Cancer Institute 2013a, b). Advances in treat-
ment have led to excellent survival and longer life ex-
pectancy (Fenlon et al. 2013). However, older women
with co-morbid conditions and breast cancer represent a
growing population who may be living longer, but not
necessarily better after completion of successful cancer
therapy (Fenlon et al. 2013; Bellury et al. 2012; Ganz
et al. 2003). Decline in physical function, increased social
isolation, and diminished economic resources may in-
crease vulnerability among older breast cancer survivors* Correspondence: andreo@uab.edu
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Cancer survivors with co-morbidities have poorer phys-
ical and mental health compared with those without
cancer (Smith et al. 2008). Among older breast cancer sur-
vivors, arthritis, hypertension, diabetes, and overweight/
obesity are most frequently reported (Bellury et al. 2012;
Weaver et al. 2013). The greater the number of co-morbid
conditions is associated with poor functional ability, in-
creased symptoms, declining overall general health and
quality of life, and increase in the number of physician
visits (Bellury et al. 2012; Bellury et al. 2013; Deimling
et al. 2009; Hays et al. 2013; Kurtz et al. 2005; Yoon et al.
2008). Social support mediates physical and mental health
status in older adults (Lachman & Agrigoroaei 2010;
Seeman 2000; White et al. 2009); and refers to real or per-
ceived resources provided by others that enable a person
to feel cared for, valued, and part of a network of commu-
nication and mutual obligation (Stroebe 2000). High levels
of social support have been associated with improvedan Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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ness (Lachman & Agrigoroaei 2010; Seeman 2000; White
et al. 2009). Social support has also been found to improve
feelings of vulnerability (Seeman 2000).
Despite the availability of studies that examine co-
morbidity and cancer, few focus on co-morbidity in rural
cancer survivors. While the reasons are unknown, the
paucity of data is consistent with the reality that rural
cancer populations are typically underserved and under-
studied (Befort & Klemp 2011). In one of the few re-
ported studies of survivors living in a semi-rural setting,
Beck et al., explored symptom experience, health-related
quality of life, and functional performance in 52 older
adults with cancer, of whom 22 were semi-rural survi-
vors (Beck et al. 2009). The investigators found that 88%
of the entire sample, including semi-rural survivors with
co-morbid disease, had poor physical status and greater
symptom intensity (Beck et al. 2009). Given this paucity
of research, and in an attempt to better understand
unique challenges and needs of rural breast cancer sur-
vivors, the investigators analyzed baseline data from the
Rural Breast Cancer Survivors study, a population-based
sample of older rural breast cancer survivors.
The specific aims of the present study are to: (1) exam-
ine associations between co-morbid conditions, and phys-
ical and mental health status among older rural breast
cancer survivors; (2) identify predictors of physical and
mental health status of older rural breast cancer survivors;
and (3) explore challenges to improve cancer survivorship
care and comprehensive geriatric assessment.
Materials and methods
Data were drawn from the parent study, the Rural Breast
Cancer Survivors Study (RBCS), a population-based
study conducted in the State of Florida evaluating the
dissemination and implementation of cancer survivor-
ship interventions among rural breast cancer survivors.
The RBCS was approved by Institutional Review Boards
and the State of Florida Department of Health (DOH).
Participants were identified through Florida cancer regis-
try. Eligibility criteria included: at least 21 years of age,
Florida rural residence, telephone access, and diagnosis
of Stage 0-III breast cancer in the previous three years.
Survivors receiving anti-hormonal therapy were eligible.
Survivors with metastatic disease, men with breast can-
cer, and those lacking reliable telephone access were not
eligible.
Rural eligibility
Rural eligibility was established using one of two criteria:
(1) residence in one of 33 Florida rural counties designated
by Florida statute; or (2) residence in a rural area of an
urban county having an Index of Research Access (IRA)
score equal to or greater than 4 (Florida Department ofHealth 2007; The Authors 2012). The IRA indicates the
level of difficulty of treatment or research access, provid-
ing a description that cannot be obtained by county resi-
dence alone. Information and details for calculating the
IRA are reported elsewhere (The Authors 2012).
Consent process and data collection
A total of 432 rural BCS enrolled. Data were collected at
baseline and every three months for a total of 12 month
participation. Self-report data from participants was col-
lected via the telephone. Data for the present study were
derived using baseline data from 331 rural BCS ages 55
to 90 years.
Variables of interest
The following variables were examined: (1) health status,
(2) co-morbid conditions, (3) sociodemographic and treat-
ment characteristics, and (4) social support.
Health status
The Medical Outcomes Study Short Form v1 (SF-36) was
used to assess self-reported health status (Ware &
Sherbourne 1992). The SF-36 has 36 items that aggregate
into two overall summary scores: the Physical Component
Summary score (PCS) and the Mental Component Sum-
mary score (MCS). The PCS was used as measure of phys-
ical health status, and the MCS was used as a measure of
mental health status. Norm scores range from 0 to 100
where higher scores indicate better functioning and health
status. In the present study, the PCS and the MCS had
alpha reliability of .93 and .90 respectively.
Co-morbid conditions
The reported number of categories of prescription medi-
cation was used as a proxy for co-morbid conditions. This
variable was measured using 22 items contained in the
Work and Finances Inventory used in prior studies by the
investigators (The Authors 2007). Three additional items
related to economic events since end of cancer treatment.
Sociodemographic and treatment characteristics
The Breast Cancer Survivor Sociodemographic Treatment
Survey has been used in prior work by the investigators
(The Authors 2007). The survey consists of 26 items: 12
sociodemographic; 12 on breast cancer treatment; two on
weight and height.
Social support
The Medical Outcomes Study Social Support (MOS-
SSS) questionnaire assessed social support (Sherbourne
& Stewart 1991). The 19 items are averaged and re-
scaled into an overall functional social support index,
with scores ranging from 0 to 100, with higher scores
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functional social support index was 0.96.
Data analysis
Participant characteristics were tabulated, including fre-
quencies for each prescription category. Bivariate tests of
association between SF-36 PCS and MCS scores and par-
ticipant characteristics were conducted using general linear
models to produce ANOVA-equivalent tests. The prescrip-
tion categories most strongly associated with SF-36 PCS
and MCS scores were tabulated. To determine covariate-
adjusted associations between number of prescriptions and
the SF-36 PCS and MCS scores, multivariable analyses
were conducted considering sociodemographics, cancer
treatment, and social support as additional predictors of
SF-36 PCS and MCS scores.
The multivariable analyses were conducted using condi-
tional inference tree modeling, a statistical technique for
recursive partitioning (Everitt & Hothorn 2009). Tree
modeling allows detection of complex interactions among
predictors that cannot be uncovered via traditional linear
model analysis (The Authors 2011a). The conditional in-
ference tree modeling procedure conducts predictor selec-
tion and partitioning of the predictor space via statistical
tests (i.e., permutation tests, a class of non-parametric
tests), while applying a strong control for multiple testing
using Bonferroni adjustments to prevent over-fitting. Un-
like linear models, tree models are not typically described
by equations but are shown graphically.
Prior to conducting the multivariable analyses, a small
proportion of missing data (approximately 1%) was im-
puted using the Multivariate Imputation by Chained
Equations (MICE) procedure, with CART (Classification
And Regression Trees) as underlying modeling tech-
nique (Hothorn et al. 2006; van Buuren & Groothuis-
Oudshoorn 2011). A single imputation was used due to
the minimal amount of missing data points. The above
analyses were conducted using SAS v9.3 statistical soft-
ware, along with the Packages Party and MICE in the R
statistical software v3.0.1 (Everitt & Hothorn 2009; van
Buuren & Groothuis-Oudshoorn 2011). Statistical sig-
nificance was held at the traditional 0.05 level.
Results
Sociodemographic characteristics
Sociodemographic characteristics among the sample are
listed in Table 1 (left columns 1 and 2). The sample was
divided into three groups: young old (age 55–64), old
(65–70), and the very old (71–90) years. Age showed a
bimodal distribution with the young old and the very old
having the largest number of participants (71.6%). The
majority were Caucasian (95%), had technical school or
some college education (34.5%), retired (58.3%), and
health insurance (95.8%). About 71% was married orliving with a partner. More than 65% had social support
scores greater than 76% indicating good social support.
Twenty-three percent reported incomes under $30,000.
Nearly 39% reported a decrease in income level; 25.4%
reported an adverse change in economic lifestyle; with
10.6% reported having to borrow money since comple-
tion of cancer therapy.Body weight
Body mass index (BMI) was divided into four categories:
underweight, normal weight, overweight and obese, based
on CDC definitions (Centers for Disease Control 2011).
More than 33% were overweight; and more than 35% were
obese.Treatment characteristics
Table 2 displays cancer treatment characteristics. Nearly
80% completed primary breast cancer treatment more
than a year prior to entering the study. The majority had
lumpectomy (60.7%) and radiation therapy for local con-
trol of disease (70.7%), and chemotherapy (52.3%) for re-
gional and systemic control of disease. Nearly 66%
received hormonal blocking agents to reduce the risk for
recurrence.Prescriptions
Table 3 shows the mean number of 3.68 prescription cat-
egories with a range of 0–12 prescription categories re-
ported by participants. The most common prescription
category was anti-hormonal agents for cancer reported by
66.2% (n = 219) of participants. High blood pressure and
high cholesterol were second and third highest with 48.6%
(n = 161) and 38.7% (n = 128) respectively, indicating that
cardiovascular disease was the most commonly treated
co-morbidity in this sample. Four medication categories
reported are commonly associated with breast cancer
treatment or side effects include: pain (19.9%), depression
(14.8%), insomnia/sleep (14.2%), anxiety (13.9%) and hot
flashes (5.4%).
The larger the number of prescription categories was
significantly associated with lower PCS score (Table 1).
A similar relationship was observed between the number
of prescriptions and the MCS score, but did not reach
statistical significance. Individual prescription categories
most strongly associated with PCS scores were pain,
heartburn, diabetes, bladder spasms, infections, allergies,
and other-not listed (Table 4). Medication categories
most strongly associated with MCS scores were anxiety,
depression, insomnia, and diabetes (Table 5). Taking
medication for diabetes was associated with both lower
PCS and MCS scores.
Table 1 SocioDemographic characteristics and bivariate test of association with SF-36 Physical Component Summary
Score (PCS) and Mental Component Summary Score (MCS) (N = 331)
Characteristic n (%) SF-36 PCS, SF-36 MCS,
mean (SD) mean (SD)
Age groups P = 0.339 P < .001
55-64 125 (37.8) 45.8 (11.27) 46.35 (11.97)
65-70 94 (28.4) 44.35 (10.89) 49.63 (11.52)
71-90 112 (33.8) 43.82 (9.83) 52.21 (10.62)
Number of prescription categories* P < .001 P = 0.164
0-2 110 (33.3) 47.49 (10.75) 50.41 (11.98)
3-4 115 (34.7) 45.39 (9.87) 49.77 (10.69)
5-12 106 (32.0) 41.13 (10.59) 47.54 (12.14)
Marital status P = 0.354 P = 0.404
Never married 5 (1.5) 49.5 (5.17) 52.08 (8.34)
Married or living w/partner 235 (71) 45.03 (10.68) 49.72 (11.15)
Separated/divorced/widowed 91 (27.4) 43.65 (10.93) 47.94 (12.94)
Ethnicity P = 0.421 P = 0.701
Caucasian 315 (95.2) 44.61 (10.67) 49.32 (11.62)
Non-Caucasian Minority 16 (4.8) 46.82 (11.39) 48.17 (12.29)
Education P = 0.227 P = 0.025
< High school 19 (5.7) 43.08 (10.46) 44.21 (11.05)
High school graduate 75 (22.7) 44.7 (10.29) 48.61 (12.27)
Technical school/some college 114 (34.5) 43.22 (10.48) 48.03 (12.68)
Completed college 76 (22.9) 46.53 (10.87) 52.44 (9.43)
Postgraduate 47 (14.2) 46.12 (11.47) 50.27 (10.42)
Employment status P < .001 P = <.001
Full-time 56 (16.9) 48.43 (8.94) 48.15 (10.06)
Part-time 48 (14.5) 46.42 (10.42) 48.69 (11.77)
Retired 193 (58.3) 44.13 (10.42) 50.99 (11.47)
Homemaker 13 (3.9) 43.72 (12.83) 44.48 (11.27)
Disability 12 (3.6) 31.71 (11.96) 35.47 (11.86)
Unemployed 9 (2.8) 43.93 (10.15) 47.86 (11.18)
Health insurance P = 0.581 P = 0.008
No 14 (4.2) 43.17 (12.06) 41.25 (13.1)
Yes 317 (95.8) 44.79 (10.65) 49.62 (11.46)
BMI category* P < .001 P = 0.645
Underweight (<18.5) 4 (1.2) 43.3 (12.17) 55.65 (3.75)
Normal (18.5 to 24.9) 98 (30.3) 49.28 (9.26) 49.12 (11.77)
Overweight (25 to 29.9) 107 (33.2) 46.21 (10.04) 49.87 (11.63)
Obese (≥30) 114 (35.3) 39.76 (10.26) 48.85 (11.35)
MOS overall social support score P = 0.018 P < .001
12-50 45 (13.6) 40.55 (10.74) 40.45 (13.09)
51-75 69 (20.8) 45.7 (10.36) 46.32 (10.96)
76-100 217 (65.6) 45.28 (10.65) 52.03 (10.36)
Family income P = 0.023 P = 0.002
$20,000 or less 55 (16.6) 43.61 (11.56) 45.08 (13.33)
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Table 2 Cancer treatment characteristics and bivariate test of association with SF-36 Physical Component Summary
(PCS) and Mental Component Summary (MCS) Scores (N = 331)
Characteristic n (%) SF-36 PCS, SF-36 MCS,
mean (SD) mean (SD)
Months since end of treatment * P = 0.709 P = 0.091
≤12 66 (20.4) 43.84 (11.04) 46.43 (12.59)
13-24 181 (56.1) 45.12 (10.43) 50 (11.49)
25+ 76 (23.5) 44.71 (11.27) 49.82 (11)
Surgery received P = 0.941 P = 0.009
Lumpectomy 201 (60.7) 44.81 (11.14) 50.32 (10.88)
Mastectomy 98 (29.6) 44.72 (10.01) 48.94 (11.84)
Bilateral mastectomy 32 (9.7) 44.11 (10.13) 43.59 (14.11)
Chemotherapy P = 0.851 P = 0.004
No 158 (47.7) 44.83 (10.55) 51.17 (11.59)
Yes 173 (52.3) 44.61 (10.86) 47.52 (11.43)
Radiation P = 0.906 P = 0.063
No 97 (29.3) 44.61 (10.16) 47.4 (13.4)
Yes 234 (70.7) 44.76 (10.93) 50.02 (10.78)
Hormonal therapya P = 0.496 P = 0.446
No 113 (34.1) 44.16 (11.15) 48.59 (13.37)
Yes 218 (65.9) 45.01 (10.47) 49.62 (10.64)
Treatment mix P = 0.184 P = 0.002
Surgery only 50 (15.1) 46.68 (9.7) 50.96 (12.71)
Surgery, chemotherapy 47 (14.2) 42.4 (10.28) 43.61 (13.21)
Surgery, radiation 108 (32.6) 44 (10.86) 51.27 (11.11)
Surgery, chemo, radiation 126 (38.1) 45.42 (10.99) 48.95 (10.41)
Notes: P-values from ANOVA tests; * Counts < 331 due to missing responses;
aOn hormonal treatment at the time the data were collected.
Table 1 SocioDemographic characteristics and bivariate test of association with SF-36 Physical Component Summary
Score (PCS) and Mental Component Summary Score (MCS) (N = 331) (Continued)
$20,001 to $30,000 54 (16.3) 41.83 (10.06) 47.56 (13.98)
$30,001 to $40,000 27 (8.2) 43.46 (12.22) 47.47 (9.19)
$40,001 to $50,000 36 (10.9) 46.36 (9.7) 48.89 (10.56)
Greater than $50,000 110 (33.2) 47.22 (9.61) 50.62 (10.33)
Declined to answer 49 (14.8) 43.04 (11.62) 54.05 (9.58)
Decrease in income levela* P = 0.283 P = 0.023
No 202 (61.1) 45.22 (10.63) 50.42 (10.82)
Yes 129 (38.9) 43.92 (10.8) 47.45 (12.65)
Borrowed moneya* P = 0.066 P < .001
No 296 (89.4) 45.09 (10.5) 50.17 (11.03)
Yes 35 (10.6) 41.58 (11.92) 41.69 (13.87)
Changed economic lifestylea* P = 0.043 P < .001
No 247 (74.6) 45.42 (10.5) 51.07 (10.65)
Yes 84 (25.4) 42.68 (11.07) 43.99 (12.8)
Notes: P-values from ANOVA tests; BMI = Body Mass Index; MOS =Medical Outcomes Study.
*Counts < 331 due to missing responses; BMI categories from Centers for Disease Control and Prevention.
aSince end of cancer treatment.
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Table 3 Frequencies of prescription categories reported
by older rural breast cancer Survivors (n = 331)
Medication category n %
Cancer (hormonal therapy) 219 66.2
High blood pressure 161 48.6












Bladder spasms 18 5.4




Congestive heart failure 4 1.2
Cough 3 0.9
Other 1 96 29
Other 2 35 10.6
Other 3 13 3.9
Prescription category counts per participant
Mean (SD) 3.68 (2.3)
Median 3
Range 0 -12
Table 4 Reported prescription categories associated with
SF-36 Physical Component Summary (PCS) Score (n = 331)
Prescription Reported? P*
No Yes
n mean (SD)a n mean (SD)a
a) Pain 265 46 (10.1) 66 39.5 (11.4) <.001
b) Heartburn 275 45.7 (10.4) 56 39.8 (10.8) <.001
c) Diabetes 291 45.4 (10.6) 40 39.5 (9.8) <.001
d) Bladder spasms 313 45.2 (10.6) 18 36.9 (10.5) 0.002
e) Infections 320 45 (10.6) 11 36.9 (10.8) 0.014
f) Allergies 294 45.2 (10.6) 37 40.9 (10.9) 0.019
e) Others not listed 235 45.6 (10.4) 96 42.5 (11.2) 0.014
aSF-36 PCS score; *t-test.
Table 5 Reported prescription categories associated with
SF-36 Mental Component Summary (MCS) Score (n = 331)
Prescription Reported? P*
No Yes
N mean (SD)a n mean (SD)a
a) Anxiety 285 50.4 (11.1) 46 42.4 (12.8) <.001
b) Depression 282 50.3 (11.3) 49 43.1 (11.7) <.001
c) Insomnia/sleep 284 50.2 (11.2) 47 43.9 (13) <.001
d) Diabetes 291 50.1 (11.2) 40 43.5 (13.4) <.001
aSF-36 MCS score; *t-test.
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Individual characteristics significantly associated with
PCS scores (Table 1, column 3 &4) included employ-
ment status, BMI, social support, family income, and
changes in economic lifestyle. Characteristics signifi-
cantly associated with MCS scores (Tables 1 and 2) were
age, education level, employment status, health insur-
ance status, social support, family income, economic
events since end of cancer (i.e., decrease in income, bor-
rowing money, and adverse changes in economic life-
style), type of surgery, and chemotherapy.
The non-linear multivariable tree model for PCS
scores (Figure 1) showed that the combination of factors
including: BMI, number of prescription categories, ad-
verse changes in economic lifestyle, and social support
were strong predictors of PCS scores. Among partici-
pants with BMI less than 31.8, the 15 participants having
the lowest average PCS of 36.7 (Figure 1, terminal node
7), reported more than two prescription categories in
combination with low levels of social support. In con-
trast, the 57 participants with the highest average PCS of
52.5 (Figure 1, terminal node 4) reported no more than
two prescription categories, and no adverse changes in
economic lifestyle since end of cancer treatment. Ninety-
three participants with high BMI (over 31.88) reported
low average PCS of 38.5 (Figure 1, terminal node 9), or
approximately one standard deviation below the U.S. adult
average.
The non-linear multivariable tree model for MCS scores
(Figure 2) showed that the combination of social support,
adverse changes in economic lifestyle, and the number of
prescription categories were strong predictors of MCS
scores. The tree model revealed that the number of pre-
scription categories was an important factor among 63
participants having at least midrange levels of social sup-
port, and who also reported adverse changes in economic
lifestyle since end of cancer treatment. Among these par-
ticipants, 31 who reported no more than three prescription
categories (Figure 2, terminal node 8) had an average
MCS of 50.4 which was almost a standard deviation higher
than the average among 32 who reported more than
three prescription categories estimated at 41.5 (Figure 2,
Figure 1 Conditional inference tree model for SF-36 Physical Component Summary (PCS) score (n=331). Notes: Correlation between
actual and predicted= 0.47, P<.0001; Predicted SF-36 PCS per terminal node: Node 4= 52.54; Node 5= 45.72; Node 7= 36.70; Node 8= 46.47;
Node 9= 38.46.
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midrange social support scores (Figure 2, terminal
node 2) had the lowest average MCS at 40.2. In con-
trast, 154 participants who reported no adverse changes
in economic lifestyle and levels of social support of at
least 79% of the maximum scores had the highestFigure 2 Conditional inference tree model for SF-36 Mental Compone
actual and predicted= 0.48, P<.0001; Predicted SF-36 MCS per terminal nod
Node 9= 41.53.average MCS of 54.2, or 40% of a standard deviation
above the general U.S. adult average MCS score.
Discussion
Significant associations between co-morbidity and health
status were noted. The majority was overweight or obesent Summary (MCS) score (n=331). Notes: Correlation between
e: Node 2= 40.18; Node 5= 49.06; Node 6= 54.21; Node 8= 50.43;
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ical health and poor mental health. Implications of this
finding are exacerbated by the reality that increased BMI
is a risk factor for many diseases including cardiovascu-
lar disease, selected cancers, diabetes, and other ailments
(World Health Organization 2013).
The second comorbidity after cancer was cardiovascu-
lar disease. Anti-hypertensives and cholesterol-reducing
medications were second and third in frequency. While
these percentages are lower than the national average
for these conditions, they represent an important health
concern among aging women with breast cancer
(American Heart Association 2013a, b).
Over 12% of survivors reported medication for diabetes.
In a sample of survivors of mixed cancers, Stava et al.
found that diabetes affected health and psychosocial well-
being outcomes (Stava et al. 2007). Our findings showed
similar results. Furthermore, findings showed that diabetes
had a significant association with both poor physical and
mental health status, indicating a compounding effect of
this particular disease on one's overall health and function.
The percentage reporting medication use for diabetes is
slightly smaller than the national incidence (16.75%) of
women older than 55 years (Centers for Disease Control
and Prevention 2011). Lower reported usage of diabetes
medication compared to the national incidence raises the
possibility of greater risk due to undiagnosed, and thus,
unmanaged diabetes.
Survivors continued to experience late effects of can-
cer beyond two years after treatment. Problems with
pain, depression, insomnia/sleep problems, anxiety, and
hot flashes are bothersome late effects of treatment.
These symptoms can disrupt activities of daily living and
influence overall perceptions of quality of life.Predictors of health status
Physical health status
The tree model illustrating significant predictors of
physical health status was the combination of several
factors including BMI, number of prescription categor-
ies, adverse changes in economic lifestyle, and social
support. Older rural breast cancer survivors who were
obese reported, on average, poor physical health. How-
ever, older rural breast cancer survivors who were not
obese but have more than two co-morbid conditions
and low levels of social support reported, on average, the
poorest physical health. In contrast, older rural breast
cancer survivors who were not obese and reported hav-
ing less than two co-morbid conditions with no adverse
changes in economic lifestyle reported the highest aver-
age physical health. Overall, participants having more
than two comorbid conditions or were obese had poor
levels of physical health.Mental health status
The tree model also illustrated that significant predictors
of mental health status were the combination of co-
morbid conditions, social support, and adverse economic
changes. The tree model revealed that the number of co-
morbid conditions was a significant predictor of mental
health among participants having at least moderate
levels of social support and who experienced adverse
economic events since completion of cancer treatment.
Those with three or less co-morbid conditions had sig-
nificantly higher mental health compared with those
having more than three. Those with high levels of social
support and no adverse economic lifestyle events had
the highest level of mental health. Those with less than
moderate levels of social support had the lowest level of
mental health.
Challenges in survivorship care and geriatric assessment
This sample of older rural breast cancer survivors
reflected general aspects of the rural population of
women living in the State of Florida. About 16% re-
ported annual household incomes of less than $20,000
which is lower than the state average poverty level of
17.1% (Spotlight on Poverty and Opportunity 2013).
More than 94% reported having health insurance, a fig-
ure greater than the state average of 80%, and received
standard treatment consistent with current breast cancer
treatment guidelines (Spotlight on Poverty and Oppor-
tunity 2013; National Comprehensive Cancer Network
2013).
Participants reported a decrease in income level,
changes in economic lifestyle, and having to borrow
money after breast cancer therapy ended. Limited re-
sources, economic burden, and unexpected economic
events can have an impact on health. Previous data indi-
cates that women with metastatic cancer and older
breast cancer survivors receiving chemotherapy experi-
ence economic burden (Sail et al. 2012; Wan et al.
2013). Our data showed that economic burden also oc-
curred in older women with early stage I and II disease.
Rural breast cancer survivors may carry disproportionate
economic burden because they may have larger travel
expenditures and out of pocket costs to seek cancer
follow-up care and survivorship services (The Authors
2011b). This burden may be exacerbated by less dispos-
able income or savings available.
Social and relational support is critical to one’s life,
and its protective role in health maintenance and quality
of life are well known (Steptoe et al. 2013; Barber 2013;
Hanratty et al. 2013). Our findings further support the
vital function of social support, and underscore the need
to assess available social support that may buffer decline
among older rural breast cancer survivors. In addition,
broader socio-environmental factors such as rurality,
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ence with adverse economic events may be particularly
critical to assess in breast cancer survivors.
The combination and influence of co-morbidity, social
support, and adverse economic lifestyle events on phys-
ical and mental health underscore the importance of
comprehensive and multi-dimensional evaluation be-
yond standard cancer survivorship care planning. Com-
prehensive geriatric assessment can be incorporated
with cancer survivorship care planning for earlier identi-
fication of vulnerable elders to maintain independence,
and plan for necessary resources (Balducci 2003; Bellury
et al. 2011). Primary care providers who are involved in
cancer care of older cancer survivors remain a critical
group to improve current models of survivorship care
(Bowman et al. 2010).
While all breast cancer survivors may be at risk of not
receiving services that may make a difference in their
post-treatment quality of life, rural dwelling women may
be at particular risk. Understanding the exact nature of
similarities and differences in rural versus urban dwell-
ing women may help ameliorate some of the these risks
and provide guidance as to precise nature of services
that are warranted.
Future research implications
Findings documented the differential types of co-morbidity
among older rural breast cancer survivors, and the poten-
tial implications for declining physical and mental health.
Development of future interventions designed to promote
better physical and emotional well-being, social support,
and communication among older rural breast cancer sur-
vivors are warranted.
Methodological considerations serve to caution re-
searchers against excluding older cancer survivors with
co-morbidity from study participation (McCaskill-Stevens
& Abrams 2011). Given the dearth of information con-
cerning older, rural breast cancer survivors in the United
States, further attention can be paid to include this popu-
lation in cancer research. However, the increasing com-
plexity in this patient population may not be fully
addressed by current cancer research paradigms (Stommel
& Schoenborn 2009). Additional work and understanding
are needed.
Limitations
Several limitations are noted. First, participants with either
an undiagnosed or untreated health condition would lead
to under-detection in the data. Second, while the total
number of co-morbid conditions listed in the survey in-
strument was large (n = 22), the list of co-morbid condi-
tions was not comprehensive, and therefore certain health
conditions may not have been detected. For example, some
participants described having joint or musculoskeletalpain. This type of pain is a known side effect of aromatase
inhibitor therapy for which they may have been taking pain
medication. Yet, a specific prescription category for joint
or musculoskeletal pain and arthritis was not contained in
the study instrument. Third, BMI was calculated by self-
report of weight and height, which may have resulted in
inaccurate estimates of actual BMI, particularly at the very
low or very high end of weight (McCaskill-Stevens &
Abrams 2011).
Finally, the possible critically important role of dia-
betes in this population is recognized. Yet, we do not
know if the present sample had a lower incidence of dia-
betes or if they had a higher incidence of undiagnosed
diabetes. If the latter is true, this would place older rural
breast cancer survivors at an even greater risk. Thus, it
is an important issue to address in future research.
Conclusion
The intersect among three factors: aging, cancer, and co-
morbid conditions represent characteristics of a growing
population of cancer survivors having unique survivorship
needs that may place them at a higher risk of vulnerability,
economic changes, and decline in social support after
treatment ends. The implications and need for future re-
search into the quality of life of older breast cancer survi-
vors are broad as the population continues to age and
people live longer after diagnosis. The complexity of needs
experienced by aging breast cancer survivors need to be
addressed. Because of the multifaceted nature of health in
cancer survivors, follow-up and survivorship care for older
breast cancer survivors would ideally include comorbid
disease, social support, and adverse changes in economic
lifestyle.
While all breast cancer survivors may be at risk for not
receiving services that may make a difference in their
post-treatment quality of life, rural dwelling women may
be at particular risk. Understanding the exact nature of
similarities and differences in ruaral versus urban dwelling
women may help ameliorate some of these risks and pro-
vide guidance as to precise nature of services that are
warranted.
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